Detalhe da pesquisa
1.
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.
Mol Cancer Ther
; 21(4): 502-510, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086951
2.
A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.
Mol Cancer Ther
; 18(10): 1822-1831, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395691
3.
A cell-penetrating bispecific antibody for therapeutic regulation of intracellular targets.
Mol Cancer Ther
; 11(10): 2169-73, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22863609
4.
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
Cancer Discov
; 1(6): 524-38, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22145100
5.
Array-based methods for identifying protein-protein and protein-nucleic acid interactions.
Methods Enzymol
; 350: 499-512, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12073332
6.
IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.
Cancer Res
; 68(24): 10215-22, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074889
7.
AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.
J Biol Chem
; 279(4): 2737-46, 2004 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-14576155